Experts of the Russian Research Center Gamalei found that all test specimens performed on revaccinated with Sputnik-V vaccine possess neutralizing antibodies against it Omicron mutation of coronavirus.
This is stated in a statement posted on the Twitter account of the Russian vaccine, which cites a relevant research of the aforementioned institute that developed the said preparation, transmits the ΑΠΕ ΜΠΕ.
“We found that all the vaccinated had neutralizing antibodies against the coronavirus strain Omicron. In addition, the level of neutralizing antibodies against Omicron in the sera of the vaccinated was slightly higher “from the level of antibodies against the original coronavirus strain (B.1.1.1.) in the sera of the vaccinated,” the study said.
The Gamaley Center has already announced that the Sputnik-V vaccine elicits a persistent neutralizing antibody response against the Omicron strain and that it protects against serious consequences of the disease and hospitalization.
The expected efficacy of the Sputnik-V vaccine at the booster dose Sputnik Light against the new executive could exceed the 80%, notes the Russian news agency TASS.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
